ArticleFrontiers in genetics2019

Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells.

Shujun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.